The influence of hormone therapy with drospirenone-estradiol on endometrioid type endometrial cancer patients.
CONCLUSION: Postoperative hormone therapy with DRSP/E2 in EC survivors did not increase recurrence or the death rate.
PMID: 30022635 [PubMed - as supplied by publisher]
Source: Journal of Gynecologic Oncology - Category: OBGYN Tags: J Gynecol Oncol Source Type: research
More News: Cancer | Cancer & Oncology | Endometrial Cancer | Estradiol | Hormonal Therapy | Hormones | OBGYN | Statistics | Study | Women | Yasmin | Yaz